JUN 10, 2019 07:24 AM PDT

CRISPR 2.0: Using Transposons to Improve and Expand CRISPR Application

Source: Science showing cas12k binging and gene insertion. 

CRISPR-cas9, commonly referred to simply as CRISPR, is a bacterial immune system that was first used as a gene-editing tool in 2012.  Since the first application to gene-editing, CRISPR has made gene-editing faster, easy to design, and easy to execute.  Resistance to CRISPR in human gene therapy is due to the risk of "off-target" effects.  Though the risk is small, and debated, off-target effects can be devastating and irreversible.  Additionally, CRISPR is very useful in deleting or inactivating genes, but scientists have found it very difficult to use it to insert or repair genes.  While studies that demonstrate CRISPR's application continues, some scientists like Feng Zhang at the Broad Institute, have focused on making CRISPR more precise.  

A team of scientists from the Broad Institute and the National Institutes of Health have engineered a CRISPR system which makes use of transposon activity to increase the specificity of gene-insertion and decrease the risk of off-target effects.  The new mechanism is a sandwich with a shCAST loci in the middle, a transposase gene at one end, and a  cas12k protein at the other.  The shCAST locus is a type of CRISPR system which was isolated from a cyanobacterium.  The job of shCAST is to integrate DNA at a specific site determined by the transposase.  The transposase gene is called Tn-7, and like all transposons (or, "jumping genes") it can move around the genome.  Tn-7 copies and pastes the gene it is attached to it in the engineered sandwich.  Tn-7 precisely identifies the insertion site 60-66bp downstream of the protospacer sequence in shCAST.  Lastly, cas12k is a protein sequence with the function of finding the protospacer sequence for Tn-7.  All together, cas12k finds the protosequence, Tn-7 moves 60-66bp downstream of that sequence and then makes copies of the gene intended for insertion.  Finally, shCAST inserts copies of the gene that Tn-7 synthesized.  

Source: Harvard showing a basic schematic of transposons. 

This new gene-editing technology has a successful insertion rate of 80% but has only been tested in bacterial organisms.  Extensive experimentation in eukaryotic cells is needed before the technology can be considered for medical application.  Still, finding possible solutions to the risks of CRISPR, only seven years after the groundbreaking technology was first used as a gene-editing tool, is exciting.

 

Sources: Discover Magazine, Science, GenomeWeb, NewScientist, Harvard

About the Author
  • Intern research scientist genetically engineering yeast to making a renewable fuel. Interested in food/water security, sustainable fuel, and sustainable farming.
You May Also Like
JUN 20, 2019
Genetics & Genomics
JUN 20, 2019
Rare Type of Genetic Mutation to Blame for Inherited Metabolic Disorder
Inherited metabolic disorders, in which the body is unable to break down a specific nutrient, are usually caused by an error in one gene....
JUN 20, 2019
Cell & Molecular Biology
JUN 20, 2019
Antidote to Deadly Box Jellyfish Venom Developed Using CRISPR
The Australian box jellyfish can be deadly. They are the most venomous marine creature, and one can kill up to 60 people....
JUN 20, 2019
Genetics & Genomics
JUN 20, 2019
Understanding Why Some Birth Defects are More Common in Girls
The p53 gene stops tumors from forming. Researchers found that the tumor-suppressing gene also has a critical role in neural tube formation....
JUN 20, 2019
Genetics & Genomics
JUN 20, 2019
Structural Biology Research Shows how Transcription Errors can Lead to Disease
The relationship between the genome of an organism and its physical characteristics can be challenging to understand. New work can reveal more....
JUN 20, 2019
Cell & Molecular Biology
JUN 20, 2019
Upending Dogma, Organs Found to be a Mix of Young and Old Cells
Researchers were surprised to find that neurons aren't the only aged cells in the body....
JUN 20, 2019
Genetics & Genomics
JUN 20, 2019
Genetic Link to Heart Disease is Stronger Than Thought
Previous work did not look at the impact of small changes in regulatory genes....
Loading Comments...